Search

Your search keyword '"Tettamanti, Massimo"' showing total 9 results
Start Over Author "Tettamanti, Massimo"
9 results on '"Tettamanti, Massimo"'

1. Thermal reaction kinetics and mechanism of PCDF, PCDD, and PCB parent compounds and activated carbon on silica

Author

Lasagni, Marina, Collina, Elena, Tettamanti, Massimo, and Pitea, Demetrio

Subjects
Biodegradation -- Methods, Polychlorinated biphenyls -- Biodegradation, Dioxin -- Research, Dibenzofurans -- Research, Environmental issues, Science and technology
Abstract

Polychlorinated dibenzo-p-dioxins (PCDD), dibenzofurans (PCDF) and biphenyls (PCB) are environmental pollutants that have been the subject of several biological degradation studies. One approach to understanding the reactivity and toxicity of PCDD, PCDF and PCB is to investigate the thermal behavior of their parent compounds through the amount of activated carbon in air, with total organic carbon as a parameter. Experiments using this approach are presented.

Published
1996

8. Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People

Author

Franchi, C, Ardoino, I, Rossio, R, Nobili, A, Biganzoli, Em, Marengoni, A, Marcucci, M, Pasina, L, Tettamanti, M, Corrao, S, Mannucci, Pm, Salerno, F, Sparacio, E, Alborghetti, S, Di Costanzo, R, Eldin, Tk, Djade, Cd, Prisco, D, Silvestri, E, Cenci, C, Barnini, T, Delitala, G, Carta, S, Atzori, S, Guarnieri, G, Zanetti, M, Spalluti, A, Serra, Mg, Bleve, Ma, Vanoli, M, Grignani, G, Casella, G, Gasbarrone, L, Maniscalco, G, Gunelli, M, Tirotta, D, Brucato, A, Ghidoni, S, Di Corato, P, Bernardi, M, Li Bassi, S, Santi, L, Agnelli, G, Marchesini, E, Mannarino, E, Lupattelli, G, Rondelli, P, Paciullo, F, Fabris, F, Carlon, M, Turatto, F, Baroni, Mc, Zardo, M, Manfredini, R, Molino, C, Pala, M, Fabbian, F, Nuti, R, Valenti, R, Ruvio, M, Cappelli, S, Paolisso, G, Rizzo, Mr, Laieta, Mt, Salvatore, T, Sasso, Fc, Utili, R, Durante Mangoni, E, Pinto, D, Olivieri, O, Stanzial, Am, Fellin, R, Volpato, S, Fotini, S, Barbagallo, M, Dominguez, L, Plances, L, D'Angelo, D, Rini, G, Mansueto, P, Pepe, I, Licata, G, Calvo, L, Valenti, M, Borghi, C, Strocchi, E, Rinaldi, Er, Zoli, M, Fabbri, E, Magalotti, D, Auteri, A, Pasqui, Al, Puccetti, L, Pasini, Fl, Capecchi, Pl, Bicchi, M, Sabbà, C, Vella, Fs, Marseglia, A, Luglio, Cv, Palasciano, G, Modeo, Me, Aquilino, A, Raffaele, P, Pugliese, S, Capobianco, C, Postiglione, A, Barbella, Mr, De Stefano, F, Fenoglio, L, Brignone, C, Bracco, C, Giraudo, A, Musca, G, Cuccurullo, O, Cricco, L, Fiorentini, A, Cappellini, Md, Fabio, G, Seghezzi, S, De Amicis MM, Fargion, S, Bonara, P, Bulgheroni, M, Lombardi, R, Porzio, M, Periti, G, Magrini, F, Massari, F, Tonella, T, Peyvandi, F, Tedeschi, A, Moreo, G, Ferrari, B, Roncari, L, Monzani, V, Savojardo, V, Folli, C, Magnini, M, Mari, D, Rossi, Pd, Damanti, S, Prolo, S, Lilleri, Ms, Micale, G, Podda, M, Selmi, C, Meda, F, Accordino, S, Conca, A, Monti, V, Corazza, Gr, Miceli, E, Lenti, Mv, Padula, D, Balduini, Cl, Bertolino, G, Provini, S, Quaglia, F, Murialdo, G, Bovio, M, Dallegri, F, Ottonello, L, Quercioli, A, Barreca, A, Secchi, Mb, Ghelfi, D, Chin, Ws, Carassale, L, Caporotundo, S, Anastasio, L, Sofia, L, Carbone, M, Traisci, G, De Feudis, L, Di Carlo, S, Davì, G, Guagnano, Mt, Sestili, S, Bergami, E, Rizzioli, E, Cagnoni, C, Bertone, L, Manucra, A, Buratti, A, Tognin, T, Liberato, Nl, Bernasconi, G, Nardo, B, Bianchi, Gb, Giaquinto, S, Benetti, G, Quagliolo, M, Centenaro, Gr, Purrello, Francesco, Di Pino, A, Piro, Salvatore, Mancuso, G, Calipari, D, Bartone, M, Gullo, F, Cortellaro, M, Magenta, M, Perego, F, Meroni, Mr, Cicardi, M, Marina, Ag, Sacco, A, Bonelli, A, Dentamaro, G, Rozzini, R, Falanga, L, Giordano, A, Perin, Pc, Lorenzati, B, Gruden, G, Bruno, G, Montrucchio, G, Greco, E, Tizzani, P, Fera, G, Di Luca ML, Renna, D, Perciccante, A, Coralli, A, Tassara, R, Melis, D, Rebella, L, Menardo, G, Bottone, S, Sferrazzo, E, Ferri, C, Striuli, R, Scipioni, R, Salmi, R, Gaudenzi, P, Gamberini, S, Ricci, F, Morabito, C, Fava, R, Semplicini, A, Gottardo, L, Vendemiale, G, Serviddio, G, Forlano, R, Bolondi, L, Rasciti, L, Serio, I, Masala, C, Mammarella, A, Raparelli, V, Rossi Fanelli, F, Delfino, M, Amoroso, A, Violi, F, Basili, S, Perri, L, Serra, P, Fontana, V, Falcone, M, Landolfi, R, Grieco, A, Gallo, A, Zuccalà, G, Franceschi, F, De Marco, G, Chiara, C, Marta, S, Bellusci, M, Setti, D, Pedrazzoli, F, Romanelli, G, Pirali, C, Amolini, C, Rosei, Ea, Rizzoni, D, Castoldi, L, Picardi, A, Gentilucci, Uv, Mazzarelli, C, Gallo, P, Guasti, L, Castiglioni, L, Maresca, A, Squizzato, A, Contini, S, Molaro, M, Annoni, G, Corsi, M, Zazzetta, S, Bertolotti, M, Mussi, C, Scotto, R, Ferri, Ma, Veltri, F, Arturi, F, Succurro, E, Sesti, G, Gualtieri, U, Perticone, F, Sciacqua, A, Quero, M, Bagnato, C, Loria, P, Becchi, Ma, Martucci, G, Fantuzzi, A, Maurantonio, M, Corinaldesi, R, De Giorgio, R, Serra, M, Grasso, V, Ruggeri, E, Carozza, Lm, Pignatti, F., Franchi, C., Ardoino, I., Rossio, R., Nobili, A., Biganzoli, E. M., Marengoni, A., Marcucci, M., Pasina, L., Tettamanti, M., Corrao, S., Mannucci, P. M, Rizzo, Mr, Mannucci, P. M., Zanetti, M., Reposi, Investigators, Biganzoli, E., Mannucci, P., Mansueto, P., Franchi, Chiara, Nobili, Andrea, Marcucci, Marianna, and Tettamanti, Massimo

Subjects
Male, TORSADES-DE-POINTES, INTERVAL PROLONGATION, PATIENT, CIPROFLOXACIN, COHORT, DEATH, MULTIMORBIDITY, AMIODARONE, MORTALITY, AIFA, Amiodarone, 030204 cardiovascular system & hematology, CIPROFLOXACIN, Logistic regression, Electrocardiography, 0302 clinical medicine, Risk Factors, Torsades de Pointes, Atrial Fibrillation, 80 and over, Prevalence, Pharmacology (medical), 030212 general & internal medicine, Aged, Aged, 80 and over, Female, Humans, Long QT Syndrome, Middle Aged, Patient Discharge, Hospitalization, media_common, Torsades de Pointe, Geriatrics and Gerontology, Medicine (all), DEATH, Cohort, Hospitalized Older People, medicine.drug, Human, Drug, medicine.medical_specialty, media_common.quotation_subject, MULTIMORBIDITY, Torsades de pointes, PATIENT, 03 medical and health sciences, Pharmacotherapy, Internal medicine, INTERVAL PROLONGATION, medicine, TORSADES-DE-POINTES, COHORT, Medical prescription, AIFA, business.industry, MORTALITY, Risk Factor, Settore MED/09 - MEDICINA INTERNA, Odds ratio, medicine.disease, QT-Prolonging Drug, Physical therapy, business
Abstract

Aims: The objective of this study was to evaluate the prevalence of the prescription of QT-prolonging drugs at hospital admission and discharge and the risk factors associated with their use in older people (aged 65Âyears and older). Methods: Data were obtained from the REPOSI (REgistro POliterapie SIMI [Società Italiana di Medicina Interna]) registry, which enrolled 4035 patients in 2008 (nÂ=Â1332), 2010 (nÂ=Â1380), and 2012 (nÂ=Â1323). Multivariable logistic regression was performed to determine the risk factors independently associated with QT-prolonging drug use. QT-prolonging drugs were classified by the risk of Torsades de Pointes (TdP) (definite, possible, or conditional) according to the Arizona Center for Education and Research on Therapeutics (AzCERT) classification. Specific drug combinations were also assessed. Results: Among 3906 patients prescribed at least one drug at admission, 2156 (55.2Â%) were taking at least one QT-prolonging drug. Risk factors independently associated with the use of any QT-prolonging drugs were increasing age (odds ratio [OR] 1.02, 95Â% CI 1.01–1.03), multimorbidity (OR 2.69, 95Â% CI 2.33–3.10), hypokalemia (OR 2.79, 95Â% CI 1.32–5.89), atrial fibrillation (OR 1.66, 95Â% CI 1.40–1.98), and heart failure (OR 3.17, 95Â% CI 2.49–4.05). Furosemide, alone or in combination, was the most prescribed drug. Amiodarone was the most prescribed drug with a definite risk of TdP. Both the absolute number of QT-prolonging drugs (2890 vs. 3549) and the number of patients treated with them (2456 vs. 2156) increased at discharge. Among 1808 patients not prescribed QT-prolonging drugs at admission, 35.8Â% were prescribed them at discharge. Conclusions: Despite their risk, QT-prolonging drugs are widely prescribed to hospitalized older persons. The curriculum for both practicing physicians and medical students should be strengthened to provide more education on the appropriate use of drugs in order to improve the management of hospitalized older people.

Published
2016

9. Ahimsa and alternatives -- the concept of the 4th R. The CPCSEA in India.

Author

Pereira S and Tettamanti M

Subjects
Animal Welfare legislation & jurisprudence, Animals, Bioethics, India, Animal Experimentation legislation & jurisprudence, Animal Rights legislation & jurisprudence, Animal Testing Alternatives legislation & jurisprudence
Abstract

The Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) in India is one of a kind in the world. It is a statutory body of the government of India formed by an act of the Indian parliament. This body consists of nominated members and representatives from national regulatory agencies, Ministry of Health and Family Welfare, Ministry of Environment and Forests, national academic and research councils, premier research institutes, eminent scientists and animal welfare organisations. The CPCSEA draws its powers from the Prevention of Cruelty to Animals (PCA) Act of 1960 which states that the duty of the committee is "to take all such measures as may be necessary to ensure that animals are not subject to unnecessary pain or suffering before, during or after the performance of experiments on them". With the power to promulgate its own laws to ensure the humane and ethical use of animals in research and education, the CPCSEA in 1998 notified in the gazette of India the "Breeding of and Experiments on Animals (Control and Supervision) Rules 1998". The CPCSEA is unique in that the law in itself has enabled the creation of a common platform of discussion for scientists and animal activists for humane and progressive solutions for the use of animals in experimentation. In a country that is caught in a paradox of violence and rich cultural and religious traditions, India still draws a lot of its power from the concept of "Ahimsa" (the philosophy of non-violence). This concept is also pertinent to the use of animals in laboratories. Unethical, inhumane and unscientific practices, and ignorance of the use of alternatives were the way of science until 1999 when CPCSEA became functional. For four years CPCSEA has waged a battle, rescued thousands of animals from laboratories, fought legal battles to victory, enforced for the first time in the country good laboratory practice, designed guidelines for the use of animals in the production of immunobiologicals, introduced the credo of 3R principles, trained and taught scientific personnel the credibility of humane science and most importantly brought forward the concept of the fourth R, "rehabilitation" of used laboratory animals. Today CPCSEA has made it a national policy that personnel using experimental animals have a moral responsibility towards these animals after their use. Costs of after-care/rehabilitation of animals post experimentation are to be a part of research costs and should be scaled in positive correlation with the level of sentience of the animals. This paper is about the Indian law on animal experimentation and the success story of the CPCSEA in India in inculcating the credo of 4Rs -- Replacement, Reduction, Refinement, and Rehabilitation of animals used in experimentation.

Published
2005

Catalog

Books, media, physical & digital resources
See catalog results